欧洲病毒学市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（诊断测试、病毒感染控制技术、抗病毒治疗和干扰素）、应用（皮肤和软组织感染、呼吸道感染、胃肠道感染、性传播））疾病、尿路感染等）和最终用户（医院、诊断实验室、制药和生物技术公司以及研究和学术机构）

市场介绍

欧洲病毒学市场包括法国、德国、英国、西班牙、意大利和欧洲其他地区的综合市场。欧洲在病毒学市场中占据重要地位，预计在预测期内将出现强劲增长。市场的增长归因于德国和英国等公司的产品开发、强大的研发活动以及对新发疾病研究的资金增加。流感对于患有慢性病的老年人来说是一种致命的疾病。德国流感的死亡率和发病率很高。根据马克斯普朗克研究所的数据，每个流感季节约有 13,600 人死亡，其中许多死亡是老年人口。 2020 年 10 月，为了降低流感和 COVID-19 同时爆发的风险，德国额外订购了 600 万剂流感疫苗。此外，根据罗伯特科赫研究所的数据，2019 年，由于医生对这些疾病的认识提高以及实验室检测的增加，戊型肝炎和钩端螺旋体病病例有所增加。由于其发达的基础设施和高投资，德国一直处于开发新技术和治疗方法的前沿。知名研究机构的入驻促进了创新疗法的推出。产品上市的增加是推动欧洲病毒学市场增长的主要因素。

新兴病毒流行病的出现出人意料，需求迅速增长采取行动阻止疾病传播。最近在全球范围内爆发的 COVID-19 凸显了迫切需要开发诊断方法、疫苗和抗病毒药物。由于 COVID-19 属于冠状病毒家族，对 MERS 的大量研究以及针对该疾病的疫苗的开发使得针对 COVID-19 的疫苗取得了快速进展。因此，开发针对潜在病毒的原型疫苗可以大大加速针对任何新出现的流行病的疫苗的开发。例如，在COVID-19之前，流行病防范创新联盟（CEPI）开发了强大的MERS候选疫苗组合，并投资了超过1.4亿美元用于MERS疫苗开发，这为后来快速应对COVID-19奠定了基础并实现了 COVID-19 疫苗的快速开发，包括牛津疫苗。此外，CEPI 于 2018 年与牛津大学建立了合作，利用其 ChadOx 疫苗平台开发针对 MERS 的疫苗。 CEPI 向牛津大学提供了额外资金，以适应该平台技术来开发针对 COVID-19 的疫苗。为了扩大 COVID-19 候选疫苗的生产规模，牛津大学随后与阿斯利康合作，阿斯利康承诺在大流行期间以非营利的方式生产该疫苗。因此，大流行的准备有助于在短时间内推出疫苗，进一步强调需要对新出现的病毒的研究进行更多投资。欧洲长期以来一直投资于新兴病毒的研究。该中心为最近的埃博拉疫情爆发提供了专业知识，目前正在研究 COVID-19。此外，疫苗的批准带来了最终克服这一流行病的希望。然而，最近的疫情爆发和新病毒株的出现影响了经济成果，大流行后将需要政府和私营部门对全球流行病和大流行病的防范做出长期承诺。

市场概况和动态

欧洲病毒学市场预计将从2021年的12.0826亿美元增长到2028年的15.2197亿美元；预计 2021 年至 2028 年复合年增长率为 3.4%。植物源疫苗和生物制药在口服给药时不需要昂贵的发酵和纯化系统以及与冷藏、运输和无菌分配相关的其他成本。一般来说，叶绿体针对细菌、病毒和原生动物病原体和生物制药提供高水平的疫苗抗原表达，并通过母系遗传来遏制转基因。在过去的八年里，用于治疗性蛋白表达的叶绿体系统已经建立。此外，最近开发的用于口服递送的高效生菜叶绿体系统是一个重大进步。此外，家庭健康诊断在患者中越来越受欢迎。作为对病毒学市场的回应，参与者正在开发家庭测试套件，以帮助轻松快速地诊断并帮助立即采取医疗措施。

关键细分市场

欧洲病毒学市场根据类型、应用、最终用户和国家/地区进行细分。根据类型，市场分为诊断测试、病毒感染控制技术、抗病毒治疗和干扰素。抗病毒治疗领域在 2020 年占据市场主导地位，病毒感染控制技术领域预计将在预测期内增长最快。诊断测试部分进一步分为DNA病毒测试、RNA病毒测试等。同样，病毒感染控制技术分为主动预防和被动预防。同样，抗病毒治疗分为杀病毒剂、抗病毒剂、免疫调节剂和干扰素。根据应用，病毒学市场分为皮肤和软组织感染、呼吸道感染、胃肠道感染、性传播疾病、尿路感染等。呼吸道感染领域在 2020 年占据市场主导地位，预计将在预测期内增长最快。根据最终用户，病毒学市场分为医院、诊断实验室、制药和生物技术公司以及研究和学术机构。医院细分市场在 2020 年占据市场主导地位，诊断实验室细分市场预计将在预测期内增长最快。

主要来源和上市公司

准备本欧洲病毒学市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有雅培（Abbott）；艾伯维公司； F.霍夫曼-拉罗氏有限公司；吉利德科学公司；葛兰素史克公司；照明公司；强生服务公司；凯杰；西门子公司；和 Thermo Fisher Scientific Inc. 等。

购买报告的理由

了解欧洲病毒学市场格局，并确定最有可能保证丰厚回报的细分市场
通过理解来保持领先地位欧洲病毒学市场不断变化的竞争格局
通过识别最有可能销售前景的细分市场，有效规划欧洲病毒学市场的并购和合作交易
帮助通过对欧洲病毒学市场各个细分市场的市场表现进行敏锐和全面的分析，做出明智的业务决策
获取欧洲地区 2021-2028 年各个细分市场的市场收入预测。

欧洲病毒学市场细分

欧洲病毒学市场 - 按类型

诊断检测
- DNA病毒检测
- RNA病毒检测
- 其他
病毒感染控制技术
- 主动预防
- 被动预防
抗病毒治疗
- 杀病毒剂
- 抗病毒药物
- 免疫调节剂
干扰素

欧洲病毒学市场 - 按应用

欧洲病毒学市场 - 按最终用户划分

医院
诊断实验室
制药和生物技术公司
研究和学术机构

欧洲病毒学市场 - 按国家/地区

< ul>

英国

德国

法国

意大利

西班牙

欧洲其他地区

li>

欧洲病毒学市场 -公司简介

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Virology Market – By Type

1.3.2 Europe Virology Market – By Application

1.3.3 Europe Virology Market – By End User

1.3.4 Europe Virology Market– By Country

2. Europe Virology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Virology Market– Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Virology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Viral Infectious Diseases

5.1.2 Increasing Product Launches

5.2 Market Restraints

5.2.1 Availability of Alternative Products and High Cost of Production of Products

5.3 Market Opportunities

5.3.1 Growth Potential in Several Economies

5.4 Future Trends

5.4.1 Continuous Demand for Cost-Effective Products

5.5 Impact Analysis

6. Virology Market– Europe Analysis

6.1 Europe Virology Market Revenue Forecast and Analysis

7. Europe Virology Market Analysis – By Type

7.1 Overview

7.2 Europe Virology Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Test

7.3.1 Overview

7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1 Overview

7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1 Overview

7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Others

7.3.2.3.1 Overview

7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Viral Infection Controlling Techniques

7.4.1 Overview

7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Active Prophylaxis

7.4.2.1.1 Overview

7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Passive Prophylaxis

7.4.2.2.1 Overview

7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Antiviral Therapeutics

7.5.1 Overview

7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Virucidal Agents

7.5.2.1.1 Overview

7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Antiviral Agents

7.5.2.2.1 Overview

7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Immunomodulators

7.5.2.3.1 Overview

7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Interferons

7.6.1 Overview

7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Virology Market Analysis – By Application

8.1 Overview

8.2 Europe Virology Market, by Application 2021 & 2028 (%)

8.3 Skin and Soft Tissue Infections

8.3.1 Overview

8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Respiratory Tract Infections

8.4.1 Overview

8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 GI Tract Infections

8.5.1 Overview

8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Sexually Transmitted Diseases

8.6.1 Overview

8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Virology Market Analysis – By End User

9.1 Overview

9.2 Europe Virology Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pharmaceutical and Biotechnological Companies

9.5.1 Overview

9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Research and Academic Institutes

9.6.1 Overview

9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Virology Market – Country Analysis

10.1.1 Europe Virology Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UK Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.1.1 UK Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.1.2 UK Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.1.2.1 UK: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.1.2.2 UK: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.1.2.3 UK: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.1.3 UK Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.1.4 UK Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.2 Germany Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.2.1 Germany Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.2.2 Germany Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.2.2.1 Germany: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.2.2.2 Germany: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.2.2.3 Germany: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.2.3 Germany Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.2.4 Germany Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.3 France Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.3.1 France Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.3.2 France Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.3.2.1 France: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.3.2.2 France: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.3.2.3 France: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.3.3 France Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.3.4 France Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.4 Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.4.1 Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.4.2 Italy Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.4.2.1 Italy: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.4.2.2 Italy: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.4.2.3 Italy: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.4.3 Italy Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.4.4 Italy Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.5 Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.5.1 Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.5.2 Spain Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.5.2.1 Spain: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.5.2.2 Spain: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.5.2.3 Spain: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.5.3 Spain Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.5.4 Spain Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.6 Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.6.1 Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.6.2 Rest of Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.6.2.1 Rest of Europe: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.6.2.2 Rest of Europe: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.6.2.3 Rest of Europe: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.6.3 Rest of Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.6.4 Rest of Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

11. Impact of COVID-19 Pandemic on Europe Virology Market

11.1 Overview

12. Europe Virology Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Johnson and Johnson Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 F. HOFFMANN-LA ROCHE LTD.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QIAGEN

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline Plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 AbbVie Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gilead Sciences, Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2. UK Virology Market Revenue and Forecasts to 2028, By Type US$ million)

Table 3. UK Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4. UK Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5. UK Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6. UK Virology Market Revenue and Forecasts to 2028, by Application US$ million)

Table 7. UK Virology Market Revenue and Forecasts to 2028, by End User US$ million)

Table 8. Germany Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 9. Germany Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10. Germany Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11. Germany Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12. Germany Virology Market Revenue and Forecasts to 2028, by Application US$ million)

Table 13. Germany Virology Market Revenue and Forecasts to 2028, by End User US$ million)

Table 14. France Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 15. France Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16. France Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17. France Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18. France Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 19. France Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 20. Italy Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 21. Italy Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22. Italy Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23. Italy Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24. Italy Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 25. Italy Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 26. Spain Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 27. Spain Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 28. North America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 29. Spain Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 30. Spain Virology Market, by Application – Revenue and Forecast to 2028 by Application (USD Million)

Table 31. Spain Virology Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)

Table 32. Rest of Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 33. Rest of Europe Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 34. Rest of Europe Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 35. Rest of Europe Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 37. Rest of Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 38. Organic Developments Done by Companies

Table 39. Inorganic Developments Done by Companies

Table 40. Glossary of Terms, Europe Virology Market

LIST OF FIGURES

Figure 1. Europe Virology Market Segmentation

Figure 2. Europe Virology Segmentation, By Country

Figure 3. Europe Virology Market Overview

Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in Europe Virology Market

Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in Europe Virology Market

Figure 6. UK to Show Significant Growth During Forecast Period

Figure 7. Europe and PEST Analysis

Figure 8. Europe Virology Market: Impact Analysis of Drivers and Restraints

Figure 9. Europe Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10. Europe Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11. Europe Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Europe DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Europe RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Europe Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Europe Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Europe Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Europe Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Europe Antiviral Therapeutics : Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Europe Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Europe Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Europe Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Europe Virology Market, by Application 2021 & 2028 (%)

Figure 24. Europe Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Europe Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Europe GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Europe Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Europe Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Europe Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31. Europe Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Europe Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Europe Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Europe Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Europe: Virology Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 36. Europe Virology Market Revenue and Forecasts to 2028, By Country (%)

Figure 37. UK Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 38. Germany Virology Products Market Revenue and Forecasts to 2028 (US$ million)

Figure 39. France Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 40. Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 41. Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 42. Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 43. Impact of COVID-19 Pandemic on Virology Market in European Countries

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Virology market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe Virology market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample